U.S. CDC ADVISERS VOTE IN FAVOR OF RECOMMENDING PFIZER-BIONTECH COVID-19 VACCINE BOOSTER DOSE FOR 12–17 YEAR OLDS, AT LEAST 5 MONTHS AFTER SECOND DOSE
U.s. Cdc Advisers Vote In Favor Of Recommending Pfizer-Biontech Covid-19 Vaccine Booster Dose For 12–17 Year Olds, At Least 5 Months After Second Dose
January 05, 2022 at 05:08 pm
Share
Share
